This content is machine translated Lupus nephritis What is new for the practice? Kidney involvement is one of the most severe forms of lupus and is often life-threatening. In order to detect lupus nephritis (LN) at an early stage, a kidney biopsy is…
View Post 4 min This content is machine translated Cutaneous lupus erythematosus (CLE) Assessment and outlook An overview article published in 2023 summarizes current and potential future treatment strategies for CLE. It remains to be seen whether further progress in researching the pathogenetic relationships will bring…
View Post 4 min This content is machine translated Systemic lupus erythematosus The future belongs to precision medicine The multiple disease manifestations of systemic lupus erythematosus (SLE) are essentially a consequence of autoantibodies, immune complexes, and cytokines. New therapies specifically intervene in the immunopathogenesis of the complex autoimmune…
View Post 6 min This content is machine translated Systemic lupus erythematosus What can belimumab and anifrolumab do? The monoclonal antibodies belimumab and anifrolumab are both approved for the treatment of systemic lupus erythematosus (SLE). Their response is considered to be highly effective. The point at which they…
View Post 7 min This content is machine translated Lupus nephritis Special case kidney For a long time, the treatment of lupus was characterized by stagnation. However, after 20 years of frustration, there is finally movement to develop new therapeutic options. Studies have produced promising results…
View Post 5 min This content is machine translated Systemic lupus erythematosus (SLE) Besides Belimumab, other biologics soon available for the treatment of SLE? The therapeutic options available today allow the choice of an individualized therapeutic strategy. In addition to covventional immunosuppressants, biologics are becoming increasingly important. Belimumab has been approved as an add-on…
